Celltrion unveiled various clinical study results of ‘Remsima’ in Europe

Published: 2015-02-24 13:34:14

Updated: 2015-02-24 14:14:00

At the European Crohn’s and Colitis Organization (ECCO)that has been held at Barcelona, Spain, since 18 February, Celltrion unveiled the result of 6 researches to targetinflammatory bowel diseasepatients, which includes the observational study conducted in Korea.

On these 6 researches, the total 258 inflammatory bowel disease patients were analyzed, and the number of Koreans was 106 among the ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.